The world is currently witnessing a dramatic disruption of everyday life owing to the rapid progression of the coronavirus disease 2019 (COVID-19) pandemic. As the pandemic evolves, there is an urgent need to better understand its epidemiology, characterize its potential impact, and identify mitigatory strategies to avert pandemic-related mortality. There is a need for a tool or algorithm to evaluate the extent to which public health policy and/or economic preparedness measures are effectively averting COVID-19 related mortality. We present a simple and yet practical epidemiological tool, the Pandemic Efficiency Index (PEI), that can be utilized globally to test the relative efficiency of measures put in place to avert death resulting from COVID-19 infection. Using the PEI and current COVID-19-related mortality, we determined that so far Germany demonstrates the highest PEI (5.1) among countries with more than 5,000 recorded cases of the infection, indicating high quality measures instituted by the country to avert death during the pandemic. Italy and France currently have the lowest COVID-19-related PEIs. Epidemics and pandemics come and go, but local, national, and global abilities to determine the efficiency of their efforts in averting deaths is critical.
The NIH-Fogarty supported UNZA-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research (UVP) continues a multi-decade training collaboration between the University of Zambia School of Medicine/University Teaching Hospital (UNZA/UTH) and the Vanderbilt Institute for Global Health (VIGH).
The Vanderbilt Institute for Global Health (VIGH) has partnered with Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria to improve epilepsy treatment uptake. The groups will conduct a randomized trial in three cities in northern Nigeria to determine the efficacy of shifting epilepsy care to community health workers.
The Global Health Case Competition is an opportunity for undergraduate, graduate, and professional students from diverse disciplines and backgrounds to collaborate in developing innovative solutions to a global health problem. Participants compete in teams of 4-6 students. Each team must have at least three (3) different Vanderbilt or Meharry schools/colleges represented. Global health is an interdisciplinary field and draws its strength from a diversity of perspectives.
The University of Zambia (UNZA)-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research (UVP) made substantial progress on its goals of training new UNZA PhD scientists to investigate complex nutritional and metabolic factors related to long-term HIV complications and comorbidities. The paper entitled, "HIV Research Training Partnership of the University of Zambia and Vanderbilt University: Features and Early Outcomes," was recently published in Annuals of Global Health.
Marie Martin, PhD, MEd, assistant professor of Health Policy, has been named associate director for Education and Training in the Vanderbilt Institute for Global Health (VIGH). Marie Martin, PhD, MEdMartin stepped into the role at the beginning of the fiscal year, succeeding Douglas Heimburger, MD, MS, who will focus his time on leading projects with grant funding from the Fogarty International Center of the National Institutes of Health (NIH). Heimburger started in 2009 as associate director of Education and Training.
The Vanderbilt Institute for Global Health, with Aminu Kano Teaching Hospital, will conduct a 60-site cluster randomized clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers with a five-year $5.9 million federal grant, “Bridging the Childhood Epilepsy Treatment Gap in Africa (BRIDGE),” from National Institute of Neurological Disorders and Stroke of the National Institutes of Health. Edwin Trevathan, M.D., M.P.H., Amos Christie Chair in Global Health, Professor of Pediatrics and
The Vanderbilt Institute for Global Health (VIGH) has been awarded a five-year, $1.2 million federal grant from the Fogarty International Center of the National Institutes of Health to evaluate and build a research capacity program in implementation science and clinical trial management to address Ebola, Lassa fever and other viral hemorrhagic fevers (VHF) in Sierra Leone. The Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) will address gaps and improve existing research capacity at in-country partner institutions.
Vanderbilt Institute for Global Health (VIGH) has been awarded a five-year, $1.2 million renewal of its Mozambique Collaborative Research Ethics Education Program supported by the Fogarty International Center of the NIH. In Portuguese, the Formação Colaborativa em Etica na Pesquisa or FoCEP Program is tailored to Portuguese speaking Africa.